Biotech delists shares from TSXV, continues OTCBB trading

Saturday, October 13, 2007 General News J E 4
VANCOUVER, Oct. 12 /PRNewswire-FirstCall/ - Biotech Holdings (the"Company", OTCBB: BIOHF) reports that in connection with a review by the TSXVenture Exchange (the "Exchange") concerning compliance with the Exchangepolicy and requirements, which resulted in the Company's halt status onSeptember 4, 2007, the Board of Directors of the Company has decided that itis in the best interest of the Company to apply to the Exchange to delist itsshares on a voluntary basis from the Exchange. As such, the Company hasapplied to the Exchange to delist its shares on a voluntary basis from theExchange in Canada while continuing trading of the Company's shares on theOver the Counter Bulletin Board in the United States. The Company continues toreport to and be accountable to the British Columbia Securities Commission,the Alberta Securities Commission and the U.S. Securities Exchange Commission.

This release has been approved by the Board of Directors of BiotechHoldings.

Robert B. Rieveley, Pres.

On behalf of the Board of Directors

Any statements made in this release that are not based on historical factare forward-looking statements. Any forward-looking statements made in thisrelease represent management's best judgement as to what may occur in thefuture. However, actual outcome and results are not guaranteed and are subjectto certain risks, uncertainties and assumptions and may differ materially fromwhat is expressed.

CONTACT: Austin Rand at Biotech Holdings, 1-888-216-1111 (toll-free) 8a.m. to 4 p.m. Pacific time; For background information on Biotech Holdings,or to receive news updates, see; The Company can be reachedby calling (604) 295-1119

SOURCE Biotech Holdings Ltd.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Accuray Incorporated to Report First Quarter Fisca...
China Medicine's ADTZ Project Has Been Selected as...